You might
have been wondering why there has been a pause in my blog posts; rather than post
nonsense, I have been exploring some new directions.
The effects of high cholesterol are very well studied in cardiology, though not in autism. The emerging understanding from cardiology is the causal link between cholesterol formation and neuroinflammation. A little known fact is that elevated cholesterol is the norm in autism; people have asked me why, now I know and soon so will you.
It is well
known that many people with autism also have epilepsy. There are many kinds of epilepsy and seizure;
two types particularly interested me - absence seizures and non-convulsive
seizures. More of this later.
Subequent posts will present what I have learnt.
The current
combination of bumetanide + NAC + atorvastatin does continue to be effective,
but clearly there can be more.
I recently read
a paper by a researcher who concluded that he thought autism was so
heterogeneous there might well never be a drug therapy for autism. I certainly see where he is coming from, but
I think this tells us two things:-
1.
Do not
expect conventional medical research to come up with an autism drug any time
soon.
2.
It would be
wise to read up on the medical research outside the realm of autism, where perhaps
a more can-do approach and better resourcing might be evident.
This brings
me to comorbidities. In case you are not
familiar with this term, in medicine, comorbidity is the presence of one
or more disorders (or diseases) in addition to a primary disease.
In the case
of autism frequent comorbidities include asthma, high cholesterol and
seizures/epilepsy.
I decided to
start with asthma, since Monty, aged 9 and with ASD, has mild asthma and I am already
familiar with the range of treatments.
I somewhat
fancifully hypothesized that there would be an overlap in effective drug
therapies for autism and asthma; in other words what works for core autism
treatment would be effective in asthma and vice versa. Having been able to validate my hypothesis, I
moved on to look at other comorbidities.
I am currently looking at three areas.
1. Asthma and COPD
Asthma
affects 300 million people worldwide and kills about 250,000 people ayear. COPD (Chronic Obstructive Pulmonary Disease) is a more severe form of asthma
and is the third leading cause of death in the US.
I figured that
since these conditions are life threatening and widespread in developed
counties, they would be well researched and drug therapies actively sought.
2. High Cholesterol
The effects of high cholesterol are very well studied in cardiology, though not in autism. The emerging understanding from cardiology is the causal link between cholesterol formation and neuroinflammation. A little known fact is that elevated cholesterol is the norm in autism; people have asked me why, now I know and soon so will you.
3. Seizures and epilepsy
But now for
a change of subject and an interesting
link ...
Common autism drug therapy in the US
If you do
not live in the US, you may be unaware just how many drugs and supplements some
autistic children receive. It seems that
in the US, 70% of autistic children take at least 10 different potions. Not surprising, many of these can interact
with each other.
If you are
curious to see what some of these drugs are and what the common interactions are,
you will find the following paper very interesting. Its author, Theoharis
C. Theoharides, has already appeared on this blog and he will appear again when
we look at asthma and immunomodulation.
No comments:
Post a Comment
Post a comment